Aureus Pharma Licenses AurSCOPE(R) GPCR To Serono Pharmaceutical Research Institute

PARIS, April 11 /PRNewswire/ -- Aureus Pharma a leading provider of knowledge management solutions to accelerate discovery in the life sciences industry, announces that Europe's largest biotechnology company Serono has become a customer of its AurSCOPE GPCR knowledge database. In this multi-year agreement, scientists at Serono Pharmaceutical Research Institute in Geneva will have access to both the AurSCOPE knowledge database and AurQUEST, a web application designed to query Aureus' knowledge bases. The financial terms of the agreement were not disclosed.

AurSCOPE GPCR is comprised of highly detailed biological activity quantitative data from patents and journals from. G-Protein Coupled Receptors (GPCRs) are a major interest for the pharmaceutical industry as they are targets in a number of therapeutic areas including CNS, cardiovascular, metabolic disease, obesity, oncology and others.

"Aureus Pharma's knowledgebase on GPCR will provide Serono researcher's with high quality quantitative data which will complement our in-house experimental platform" commented Serono's Dr. Serge Halazy, Head of Research, Switzerland. "We are very pleased to have Serono join our growing list of customers in the pharmaceutical and biotechnology industry "said Dr. Andre Michel, CEO of Aureus Pharma. "Having access to the high quality data in AurSCOPE GCPR will aid researchers in the discovery of new GPCR targeted drugs."

About Aureus Pharma

Aureus Pharma headquartered in Paris, France is a privately held knowledge management based solutions provider for the life sciences industry. Aureus Pharma accelerates new drug discovery by providing knowledge databases which contain high quality quantitative information for both chemistry and biology. Researchers gain rapid access to knowledge for important drug target classes including GPCR, Ion Channel, Kinase as well as other critical pharmaceutical topics including

ADME/Drug-Drug Interactions and the hERG Channel. The information contained in the Aureus Pharma system is of primary importance to aid in lead discovery and optimization as well as to build predictive models. For further information on how Aureus Pharma helps researchers turn data into discovery visit www.aureus-pharma.com

Contact: Mary E. Donlan, Ph.D Director of Marketing & Sales +33-1-40-18-57-59/+33-6-76-19-51-77 mary.donlan@aureus-pharma.com

CONTACT: Contact: Mary E. Donlan, Ph.D, Director of Marketing & Sales,+33-1-40-18-57-59/+33-6-76-19-51-77, mary.donlan@aureus-pharma.com